Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
Pazianas M, Miller PD.
Am J Kidney Dis. 2021 Oct;78(4):582-589. doi: 10.1053/j.ajkd.2020.12.024. Epub 2021 Mar 25.
Bone Disease in Chronic Kidney Disease and Kidney Transplant.
Bellorin-Font E, Rojas E, Martin KJ.
Nutrients. 2022 Dec 29;15(1):167. doi: 10.3390/nu15010167.
Screening for Metabolic Bone Disease of prematurity.
Rayannavar A, Calabria AC.
Semin Fetal Neonatal Med. 2020 Feb;25(1):101086. doi: 10.1016/j.siny.2020.101086. Epub 2020 Jan 16.
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
FGF23-Related Hypophosphataemic Bone Disease.
González-Meneses López A.
Adv Ther. 2020 May;37(Suppl 2):25-28. doi: 10.1007/s12325-019-01177-0. Epub 2020 Mar 31.
Bone Disease in Mastocytosis.
Orsolini G, Viapiana O, Rossini M, Bonifacio M, Zanotti R.
Immunol Allergy Clin North Am. 2018 Aug;38(3):443-454. doi: 10.1016/j.iac.2018.04.013.
Cancer-associated bone disease.
Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Glüer CC, Kendler D, Napoli N, Papaioannou A, Pierroz DD, Rahme M, Van Poznak CH, de Villiers TJ, El Hajj Fuleihan G; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease.
Osteoporos Int. 2013 Dec;24(12):2929-53. doi: 10.1007/s00198-013-2530-3. Epub 2013 Oct 22.
Myeloma bone disease.
Callander NS, Roodman GD.
Semin Hematol. 2001 Jul;38(3):276-85. doi: 10.1016/s0037-1963(01)90020-4.
Bone kidney interactions.
Nickolas TL, Jamal SA.
Rev Endocr Metab Disord. 2015 Jun;16(2):157-63. doi: 10.1007/s11154-015-9314-3.
Bone Marrow and Metabolic Bone Disease.
Aparisi Gómez MP, Bazzocchi A.
Semin Musculoskelet Radiol. 2024 Oct;28(5):515-527. doi: 10.1055/s-0044-1788692. Epub 2024 Oct 15.
